0001493152-23-029732.txt : 20230821 0001493152-23-029732.hdr.sgml : 20230821 20230821180013 ACCESSION NUMBER: 0001493152-23-029732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230817 FILED AS OF DATE: 20230821 DATE AS OF CHANGE: 20230821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aminov Erez CENTRAL INDEX KEY: 0001986112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41765 FILM NUMBER: 231190449 MAIL ADDRESS: STREET 1: C/O MIRA PHARMACEUTICALS, INC. STREET 2: 900 WEST PLATT STREET, SUITE 200 CITY: TAMPA STATE: FL ZIP: 33606-2173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853354547 STATE OF INCORPORATION: FL BUSINESS ADDRESS: STREET 1: 855 N WOLFE STREET #623-6 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: Mira1a Therapeutics, Inc. DATE OF NAME CHANGE: 20220112 4 1 ownership.xml X0508 4 2023-08-17 0 0001904286 MIRA PHARMACEUTICALS, INC. MIRA 0001986112 Aminov Erez C/O MIRA PHARMACEUTICALS, INC. 855 N WOLFE ST., SUITE 200 BALTIMORE MD 21205 1 1 0 0 CEO and Director 0 Stock Options 6.50 2023-08-17 4 A 0 150000 0 A 2033-08-17 Common Stock 150000 150000 D The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023. The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vests in full on August 17,2023. /s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov 2023-08-21